Biomerica Correlations
| BMRA Stock | USD 0.71 0.01 0.97% |
The correlation of Biomerica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biomerica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biomerica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Significant diversification
The correlation between Biomerica and NYA is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Biomerica and NYA in the same portfolio, assuming nothing else is changed.
Biomerica |
The ability to find closely correlated positions to Biomerica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biomerica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biomerica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biomerica to buy it.
Moving together with Biomerica Stock
| 0.74 | EVH | Evolent Health Financial Report 1st of May 2024 | PairCorr |
| 0.76 | NRC | National Research Corp | PairCorr |
| 0.61 | HSTM | HealthStream | PairCorr |
| 0.78 | NUWE | Nuwellis Financial Report 14th of May 2024 | PairCorr |
| 0.66 | PRVA | Privia Health Group Financial Report 2nd of May 2024 | PairCorr |
Moving against Biomerica Stock
| 0.68 | IRIX | IRIDEX Financial Report 9th of May 2024 | PairCorr |
| 0.61 | NXL | Nexalin Technology | PairCorr |
| 0.48 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Biomerica Stock performing well and Biomerica Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Biomerica's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KIDS | 2.51 | (0.07) | 0.02 | 0.06 | 2.55 | 6.44 | 15.51 | |||
| IRTC | 2.03 | (0.02) | 0.01 | 0.07 | 3.22 | 3.98 | 21.13 | |||
| NPCE | 3.07 | (0.08) | (0.01) | 0.03 | 4.36 | 5.87 | 24.43 | |||
| ELMD | 2.79 | 0.55 | 0.28 | 0.36 | 1.95 | 6.67 | 31.67 | |||
| VREX | 1.27 | (0.29) | 0.00 | (0.18) | 0.00 | 2.26 | 10.78 | |||
| SGHT | 3.41 | 0.04 | 0.03 | 0.10 | 4.33 | 6.69 | 25.65 | |||
| APYX | 5.19 | (0.52) | 0.00 | (0.25) | 0.00 | 8.81 | 45.17 | |||
| SIBN | 1.96 | (0.38) | 0.00 | (0.19) | 0.00 | 4.10 | 18.59 | |||
| IRMD | 1.73 | (0.21) | 0.00 | (0.05) | 0.00 | 3.32 | 11.07 | |||
| LUNG | 2.54 | (0.90) | 0.00 | (0.51) | 0.00 | 3.61 | 25.81 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biomerica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Biomerica Corporate Directors
Biomerica corporate directors refer to members of a Biomerica board of directors. The board of directors generally takes responsibility for the Biomerica's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Biomerica's board members must vote for the resolution. The Biomerica board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Francis Cano | Independent Director | Profile | |
| Jane Emerson | Independent Director | Profile | |
| Janet Moore | CFO, Treasurer, Secretary and Director | Profile | |
| MBA PharmD | Executive Director of Medical Affairs and Research and Sr. Advisor | Profile |
Already Invested in Biomerica?
The danger of trading Biomerica is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biomerica is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biomerica. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biomerica is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Biomerica Stock analysis
When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.323 | Quarterly Revenue Growth (0.09) | Return On Assets (0.43) | Return On Equity (0.92) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.